Medable Announces New Software Solutions to Expedite Vaccine Trials
Solutions include pre-configured modules for vaccine clinical trials that increase operational efficiency.
Medable announced new software solutions that enable life sciences companies to expedite critical vaccine development and respond to outbreaks like COVID-19, monkeypox, and new flu variants. The solutions include pre-configured modules for vaccine clinical trials that increase operational efficiency based on industry best practices, while cutting deployment times by 50%.
Read more about the new software solutions
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
